Kevin P. Kerns

Array ( [id] => 9211601 [patent_doc_number] => 20140010778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'Controlling Bacterial Persister Cells with Host Immune Factors' [patent_app_type] => utility [patent_app_number] => 13/897842 [patent_app_country] => US [patent_app_date] => 2013-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 8853 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13897842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10149042 [patent_doc_number] => 09181317 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'Methods and compositions based on diphtheria toxin-interleukin-3 conjugates' [patent_app_type] => utility [patent_app_number] => 13/896923 [patent_app_country] => US [patent_app_date] => 2013-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 50628 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13896923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10122562 [patent_doc_number] => 09156915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Anti-GCC antibody molecules' [patent_app_type] => utility [patent_app_number] => 13/872065 [patent_app_country] => US [patent_app_date] => 2013-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29775 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13872065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10208393 [patent_doc_number] => 20150093382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'LACTOFERRIN FUSION PROTEIN AND METHOD FOR PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 14/395826 [patent_app_country] => US [patent_app_date] => 2013-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 12993 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14395826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9094295 [patent_doc_number] => 20130273606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'SECRETION YIELD OF A PROTEIN OF INTEREST BY IN VIVO PROTEOLYTIC PROCESSING OF A MULTIMERIC PRECURSOR' [patent_app_type] => utility [patent_app_number] => 13/865626 [patent_app_country] => US [patent_app_date] => 2013-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9241 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13865626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9560669 [patent_doc_number] => 20140178382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'ANTIBODIES AGAINST MONOCYTE CHEMOTACTIC PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/863574 [patent_app_country] => US [patent_app_date] => 2013-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26485 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13863574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8989253 [patent_doc_number] => 20130216534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'USE OF IL-20 ANTAGONISTS FOR TREATING RHEUMATOID ARTHRITIS AND OSTEOPOROSIS' [patent_app_type] => utility [patent_app_number] => 13/863896 [patent_app_country] => US [patent_app_date] => 2013-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18556 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13863896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9363095 [patent_doc_number] => 20140072968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'Novel Genes Encoding Proteins Having Prognostic, Diagnostic, Preventive, Therapeutic, and Other Uses' [patent_app_type] => utility [patent_app_number] => 13/860048 [patent_app_country] => US [patent_app_date] => 2013-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 38219 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13860048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9042295 [patent_doc_number] => 20130244933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'USE OF CONKUNITZIN-S1 FOR THE MODULATION OF GLUCOSE-INDUCED INSULIN SECRETION' [patent_app_type] => utility [patent_app_number] => 13/858241 [patent_app_country] => US [patent_app_date] => 2013-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15680 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13858241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10608137 [patent_doc_number] => 09328159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-03 [patent_title] => 'Multimeric IL-15 soluble fusion molecules and methods of using same' [patent_app_type] => utility [patent_app_number] => 13/854903 [patent_app_country] => US [patent_app_date] => 2013-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 113 [patent_figures_cnt] => 183 [patent_no_of_words] => 53375 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13854903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11909461 [patent_doc_number] => 09778269 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-03 [patent_title] => 'Method of treating sepsis by administering a soluble CD52 glycoprotein' [patent_app_type] => utility [patent_app_number] => 14/440703 [patent_app_country] => US [patent_app_date] => 2013-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 48 [patent_no_of_words] => 31416 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9363693 [patent_doc_number] => 20140073566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'METHODS OF USING CHIMERIC COILED-COIL MOLECULE' [patent_app_type] => utility [patent_app_number] => 13/848015 [patent_app_country] => US [patent_app_date] => 2013-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 29145 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13848015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9093757 [patent_doc_number] => 20130273068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/840828 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 48822 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13840828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977300 [patent_doc_number] => 20130210730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'METHOD OF TREATING DYSPNEA ASSOCIATED WITH ACUTE HEART FAILURE' [patent_app_type] => utility [patent_app_number] => 13/784963 [patent_app_country] => US [patent_app_date] => 2013-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 27565 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13784963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9858661 [patent_doc_number] => 20150038679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'Interleukin-3 Polypeptide Conjugates and Their Uses' [patent_app_type] => utility [patent_app_number] => 14/381193 [patent_app_country] => US [patent_app_date] => 2013-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 107035 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9134290 [patent_doc_number] => 20130295004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'IL-1 BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/775540 [patent_app_country] => US [patent_app_date] => 2013-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37431 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13775540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8989259 [patent_doc_number] => 20130216540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'MODULATION OF THE INNATE IMMUNE SYSTEM THROUGH THE TREM-LIKE TRANSCRIPT 2 PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/773039 [patent_app_country] => US [patent_app_date] => 2013-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 20219 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13773039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13748807 [patent_doc_number] => 10167335 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-01 [patent_title] => IL-1b neutralizing human monoclonal antibodies [patent_app_type] => utility [patent_app_number] => 14/378442 [patent_app_country] => US [patent_app_date] => 2013-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 17 [patent_no_of_words] => 10047 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14378442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11304808 [patent_doc_number] => 09512194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-06 [patent_title] => 'Modified IL-13 polypeptides' [patent_app_type] => utility [patent_app_number] => 14/373498 [patent_app_country] => US [patent_app_date] => 2013-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 12265 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14373498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9041085 [patent_doc_number] => 20130243722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'IL-12 FOR RADIATION PROTECTION AND RADIATION-INDUCED TOXICITY MITIGATION' [patent_app_type] => utility [patent_app_number] => 13/745698 [patent_app_country] => US [patent_app_date] => 2013-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 48210 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13745698 [rel_patent_id] =>[rel_patent_doc_number] =>)